[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

Moles-Garcia, 2021 - Google Patents

Interplay between Wnt signalling and SOX6 in the development of substantia nigra pars compacta (SNc) midbrain dopaminergic neurons

Moles-Garcia, 2021

View PDF
Document ID
8343316944881577852
Author
Moles-Garcia E
Publication year

External Links

Snippet

In Parkinson's disease (PD), degeneration of substantia nigra pars compacta (SNc) midbrain dopaminergic (mDA) neurons causes motor impairments in patients suffering from this illness. Yet, the reasons behind the selective degeneration of neuronal subpopulations and …
Continue reading at figshare.le.ac.uk (PDF) (other versions)

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
    • G01N33/5058—Neurological cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G01N33/6896—Neurological disorders, e.g. Alzheimer's disease
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues ; Not used, see subgroups
    • C12N5/0602—Vertebrate cells
    • C12N5/0618—Cells of the nervous system
    • C12N5/0619—Neurons

Similar Documents

Publication Publication Date Title
Hettige et al. FOXG1 dose in brain development
Neves et al. Differential expression of Sox2 and Sox3 in neuronal and sensory progenitors of the developing inner ear of the chick
Fritschy et al. GABAA receptors and plasticity of inhibitory neurotransmission in the central nervous system
Guo et al. Expression of pax6 and sox2 in adult olfactory epithelium
García-Huerta et al. Insulin-like growth factor 2 (IGF2) protects against Huntington’s disease through the extracellular disposal of protein aggregates
Wu et al. Onecut 1 and Onecut 2 are potential regulators of mouse retinal development
Seredick et al. Zebrafish Mnx proteins specify one motoneuron subtype and suppress acquisition of interneuron characteristics
Gascon et al. Sequential activation of p75 and TrkB is involved in dendritic development of subventricular zone‐derived neuronal progenitors in vitro
Bricaud et al. The transcription factor six1 inhibits neuronal and promotes hair cell fate in the developing zebrafish (Danio rerio) inner ear
Skalecka et al. mTOR kinase is needed for the development and stabilization of dendritic arbors in newly born olfactory bulb neurons
Moshiri et al. Sonic hedgehog regulates proliferation of the retinal ciliary marginal zone in posthatch chicks
Lui et al. Lhx1/5 control dendritogenesis and spine morphogenesis of Purkinje cells via regulation of Espin
Nakamura et al. Novel role of Rac-Mid1 signaling in medial cerebellar development
Abdouh et al. In vivo reactivation of a quiescent cell population located in the ocular ciliary body of adult mammals
Freter et al. Pax2 modulates proliferation during specification of the otic and epibranchial placodes
Szabolcsi et al. De novo expression of parvalbumin in ependymal cells in response to brain injury promotes ependymal remodeling and wound repair
Nelson et al. Relationship between delta‐like and proneural bHLH genes during chick retinal development
Lee et al. Reciprocal actions of ATF5 and Shh in proliferation of cerebellar granule neuron progenitor cells
Kadoya et al. Negative regulation of mTOR signaling restricts cell proliferation in the floor plate
Seybold et al. Substance P initiates NFAT‐dependent gene expression in spinal neurons
Rabe et al. The transcription factor Uncx4. 1 acts in a short window of midbrain dopaminergic neuron differentiation
Jones et al. Expression of the Gata3 transcription factor in the acoustic ganglion of the developing avian inner ear
Pacini et al. A Tph2 GFP reporter stem cell line to model in vitro and in vivo serotonergic neuron development and function
Moles-Garcia Interplay between Wnt signalling and SOX6 in the development of substantia nigra pars compacta (SNc) midbrain dopaminergic neurons
Peterson et al. The Basic Helix-Loop-Helix Gene Nato3 drives expression of dopaminergic neuron transcription factors in neural progenitors